Skip to main content
. Author manuscript; available in PMC: 2017 Dec 21.
Published in final edited form as: Obstet Gynecol. 2013 Jun;121(6):1309–1312. doi: 10.1097/AOG.0b013e31829007f0

Fig. 1.

Fig. 1

Plasma concentration of glyburide after a 2.5-mg oral dose in women with type 2 diabetes (n=8) or gestational diabetes (n=18). The data in this figure are taken from a subset of the data from the Obstetric-Fetal Pharmacology Research Unit collected, as described in Hebert MF, Ma X, Naraharisetti SB, Krudys KM, Umans JG, Hankins GD, et al, for the Obstetric-Fetal Pharmacology Research Unit Network. Are we optimizing gestational diabetes treatment with glyburide? The pharmacologic basis for better clinical practice. Clin Pharmacol Ther 2009;85:607–14.1

Caritis. Glyburide Use in Women With GDM. Obstet Gynecol 2013.